- Report
- April 2024
- 94 Pages
Middle East, Africa
From €2469EUR$2,485USD£2,053GBP
€3527EUR$3,550USD£2,932GBP
- Report
- April 2024
- 106 Pages
Asia Pacific
From €2469EUR$2,485USD£2,053GBP
€3527EUR$3,550USD£2,932GBP
- Report
- April 2024
- 107 Pages
Europe
From €2469EUR$2,485USD£2,053GBP
€3527EUR$3,550USD£2,932GBP
- Report
- April 2024
- 96 Pages
North America
From €2469EUR$2,485USD£2,053GBP
€3527EUR$3,550USD£2,932GBP
- Report
- December 2023
- 132 Pages
United States
From €2469EUR$2,485USD£2,053GBP
€3527EUR$3,550USD£2,932GBP
- Report
- March 2024
- 135 Pages
Middle East
From €3675EUR$3,699USD£3,055GBP
- Report
- April 2024
- 138 Pages
United States
From €3675EUR$3,699USD£3,055GBP
- Report
- July 2024
- 115 Pages
Asia Pacific
From €4719EUR$4,750USD£3,924GBP
- Report
- July 2024
- 110 Pages
Europe
From €4719EUR$4,750USD£3,924GBP
- Report
- July 2024
- 120 Pages
Europe
From €4719EUR$4,750USD£3,924GBP
- Report
- February 2024
- 112 Pages
North America
From €4719EUR$4,750USD£3,924GBP
- Report
- February 2024
- 70 Pages
Asia Pacific
From €4719EUR$4,750USD£3,924GBP
- Report
- February 2024
- 70 Pages
Africa, Middle East
From €4719EUR$4,750USD£3,924GBP
- Report
- February 2024
- 70 Pages
Latin America
From €4719EUR$4,750USD£3,924GBP
- Report
- February 2024
- 70 Pages
North America
From €4719EUR$4,750USD£3,924GBP
- Report
- February 2024
- 70 Pages
Europe
From €4719EUR$4,750USD£3,924GBP
- Report
- February 2024
- 80 Pages
Middle East, Africa
From €4719EUR$4,750USD£3,924GBP
- Report
- February 2024
- 90 Pages
Asia Pacific
From €4719EUR$4,750USD£3,924GBP
- Report
- February 2024
- 80 Pages
Europe
From €4719EUR$4,750USD£3,924GBP
- Report
- August 2024
- 180 Pages
Middle East, Africa
From €3973EUR$3,999USD£3,303GBP
The Infusions and Injectables market is a segment of the pharmaceutical industry that focuses on the production and distribution of drugs that are administered through intravenous (IV) or intramuscular (IM) injections. These drugs are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases. The market is highly competitive, with a number of large pharmaceutical companies vying for market share.
The market is divided into two main segments: branded and generic drugs. Branded drugs are typically more expensive than generic drugs, but they are often more effective and have fewer side effects. Generic drugs are typically cheaper, but they may not be as effective or have as many side effects.
Some of the major players in the Infusions and Injectables market include Pfizer, Merck, Novartis, Sanofi, and Johnson & Johnson. These companies are responsible for the production and distribution of a wide range of drugs, including cancer treatments, diabetes medications, and autoimmune therapies. Show Less Read more